Dr Shimasaki & Gillian - Aonm

Dr. Craig Shimasaki is the CEO of Moleculera Labs In Oklahoma, USA. He founded the laboratory together with Dr. Madeleine Cunningham, who has been instrumental in identifying the underlying markers of the poorly understood conditions PANDAS and PANS. Moleculera Labs is a pioneer in developing and offering advanced testing services that assist therapists in identifying whether an individual’s neurological and/or other symptoms could be caused by an autoimmune dysfunction.